You are here

Home » UW Studies COVID-19 Presence to Inform Smart Policy Decisions

UW Studies COVID-19 Presence to Inform Smart Policy Decisions

This webinar was originally recorded on Wednesday November 4, 2020. The activity EXPIRED on November 4, 2021, and is no longer available for CME credit, but the recording is still available. 

Join the Washington Medical Commission for an educational opportunity on COVID-19 research.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Recognize the difference in COVID-19 infection rates across rural/urban locations and within racially, ethnically and socioeconomically diverse communities.
  • Discuss how research findings may impact policy decisions.
  • Utilize the correct forms and procedures following a positive COVID-19 test.
  • Improve communication with patients with regards to the need for contact tracing protocols.

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Speaker Biography

Keith Jerome, MD, PhD

Dr. Keith R. Jerome is a physician and medical researcher on the faculty at the University of Washington and the Fred Hutchinson Cancer Research Center. Dr. Jerome leads the Virology Division within the Department of Laboratory Medicine and Pathology at the University of Washington (UW Virology). Under his guidance UW Virology designed and implemented molecular testing assays for a wide variety of human viruses, including SARS-CoV-2, hepatitis B and C, enterovirus , BK virus, and cytomegalovirus. The program provides diagnostic support for stem cell transplant and other patients in the Pacific Northwest, and throughout the country through its reference testing services. UW Virology has been a leader in the national response to COVID-19, providing clinical testing and support for research studies evaluating new therapies and vaccine candidates.

In addition to his clinical efforts, at Fred Hutch Dr. Jerome leads a research group focused on the biology of chronic viral infections. He has pioneered the use of gene editing and gene therapy as potentially curative therapies for HIV, hepatitis B, human papillomavirus, and herpesvirus infections. He currently serves as co-principal investigator and NIH contact investigator for defeatHIV, Fred Hutch’s Martin Delaney Collaboratory working toward a cure for HIV disease.

Dr. Jerome earned a Bachelor of Science from Georgetown College before earning a Ph.D. in Microbiology and Immunology and his M.D. from Duke University. 

Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Alden Roberts, MD
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.
However, the Washington Medical Commission gratefully acknowledges the unrestricted educational grant from the FSMB Foundation in the amount of  $10,000 to support this activity.

Federation of State Medical Boards Logo



Disclosure of Commercial Interest

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare. All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. 

The speakers, course director and planners at the Federation of State Medical Boards and the Washington Medical Commission have no relevant financial interests to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.